Deceased Oregon Woman’s Family Files GranuFlo Lawsuit

Category : Uncategorized on June 21, 2013

An Oregon woman’s family is suing Fresenius Medical Care in a GranuFlo-related wrongful death case. The family says Ms. Shannon Giltner died following her kidney dialysis treatment. According to the suit, Fresenius’ NaturaLyte and GranuFlo treatments caused Ms. Shannon Giltner to suffer an instant and unanticipated cardiac arrest. The lawsuit is joining the GranuFlo Multi-District Litigation.

Colleen Coultas, Shannon Giltner’s daughter, is the main plaintiff in the case. She filed the suit on her mother’s behalf in the United States District Court in Massachusetts, where it would join other suits in the GarnuFlo MDL that was formed in recent times. According to Coultas, her mother passed away in 2010 May because of a cardiac arrest after her dialysis treatment that involved the use of NaturaLyte and GranuFlo. Both NaturaLyte and GranuFlo had been recalled by the United States Food & Drug Administration (FDA) in year 2012 following the reports of numerous heart attacks, cardiac arrests and deaths linked to the use of these drugs at the time of regular dialysis treatments.

According to Coultas, Fresenius withheld vital information regarding the requirement to observe patient’s bicarbonate levels at the time of dialysis treatments that involved NaturaLyte and GranuFlo. The use of these drugs can significantly increase the potential of developing fatal heart issues such as cardiac arrest, stroke, low blood pressure (hypotension), and coma.

In 2013 March, the United States Judicial Panel on MDL (JPML) consolidated all federal lawsuits against Fresenius over NaturaLyte and GranuFlo in the Massachusetts District, where these cases will be presided over by a single judge at the time of pretrial proceedings. The recent court documents indicate there are nearly 161 suits in the Multi-District Litigation. In addition, there are many NaturaLyte and GranuFlo suits pending in state courts in Massachusetts.

GranuFlo, an acid concentrate powder, is used in dialysis (the process in which poisonous waste is eliminated from the human blood system using neutralizing acids which form in the blood). GranuFlo contains much more bicarbonate when compared to other brands of this drug that are available in the market. For this reason, the use of GranuFlo might result in bicarbonate overdose, which could cause fatal injuries. Though GranuFlo isn’t an inherently hazardous product, it becomes dangerous because of human mistakes such as incorrect mixing of dialysates. Fresenius Medical Care was the largest operator of dialysis centres in the United States. Its headquarters is in Waltham, Massachusetts.

Comments are closed.